Advances in Pharmacological and Pharmaceutical Sciences

Advances in Pharmacological and Pharmaceutical Sciences / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 387071 |

Mohamed A. Morsy, Salwa A. Ibrahim, Entesar F. Amin, Maha Y. Kamel, Rehab A. Rifaai, Magdy K. Hassan, "Curcumin Ameliorates Methotrexate-Induced Nephrotoxicity in Rats", Advances in Pharmacological and Pharmaceutical Sciences, vol. 2013, Article ID 387071, 7 pages, 2013.

Curcumin Ameliorates Methotrexate-Induced Nephrotoxicity in Rats

Academic Editor: Paola Patrignani
Received02 Sep 2013
Accepted06 Nov 2013
Published05 Dec 2013


Methotrexate is an effective anticancer and immunosuppressive agent. However, nephrotoxicity is one of the complications of its use. On the other hand, curcumin, a naturally occurring polyphenolic compound, is reported to have antioxidant and anti-inflammatory properties. Those two properties are likely to prevent methotrexate-induced nephrotoxicity. The aim of this study is to evaluate the possible protective effect of curcumin against methotrexate-induced nephrotoxicity and delineate various mechanism(s) underlies this effect in rats. Nephrotoxicity was induced in Wistar rats by intraperitoneal administration of methotrexate (7 mg/kg/day) for three consecutive days. Curcumin administration in methotrexate-intoxicated rats resulted in nephroprotective effects as evidenced by the significant decrease in levels of serum creatinine and urea as well as renal malondialdehyde, nitric oxide, and tumor necrosis factor-α with a concurrent increase in renal glutathione peroxidase and superoxide dismutase activities compared to nephrotoxic untreated rats. Additionally, immunohistochemical analysis demonstrated that curcumin treatment markedly reduced cyclooxygenase-2 expression. Histopathological examination confirmed the protective effects of curcumin. In conclusion, curcumin protected rats from methotrexate nephrotoxicity, at least in part, through its antioxidant and anti-inflammatory activities.

1. Introduction

Methotrexate, a folic acid antagonist, is widely used in the treatment of various malignancies and inflammatory diseases. However, nephrotoxicity is an important adverse effect of methotrexate therapy [1]. The pathogenesis of methotrexate nephrotoxicity involves multiple pathways, including oxidative stress and inflammation [2, 3]. Several agents have been used, with various degrees of success, to ameliorate or prevent methotrexate nephrotoxicity [24].

Curcumin is an active polyphenolic constituent from Curcuma longa with notable antioxidant and anti-inflammatory properties [5, 6] that render it an attractive candidate for protection against methotrexate nephrotoxicity. Curcumin has shown renal protective properties against gentamicin- and cisplatin- induced renal toxicities ([7] and [8], resp.) as well as diabetic nephropathy [9]. The present study therefore was designed to assess the possible renoprotective effect of curcumin and to examine the underlying mechanism(s) responsible for this effect in a rat model of methotrexate-induced nephrotoxicity. The mechanism of renoprotection was evaluated by assessing the oxidative stress (i.e., malondialdehyde, nitric oxide, glutathione peroxidase, and superoxide dismutase) and inflammatory (i.e., tumor necrosis factor-α [TNF-α] and cyclooxygenase-2 [COX-2]) parameters.

2. Materials and Methods

2.1. Chemicals

Curcumin was a generous gift from DBK Pharma (Cairo, Egypt). Methotrexate was a generous gift from Minapharm (Cairo, Egypt). Antibody against COX-2 was purchased from Thermo Fisher Scientific Inc./Lab Vision (Fremont, CA, USA). All other chemicals were of analytical grade and were obtained from commercial sources.

2.2. Animals and Experimental Design

Ten-week-old male Wistar rats weighing 150–180 g were used after one week for proper acclimatization to the animal house conditions (12 h lighting cycle and °C temperature) with free access to standard rodent chow and water. All experimental procedures were conducted according to the ethical standards approved by the Institutional Animal Ethics Committee guidelines for animal care and use, Minia University, Egypt. Animals were randomly divided into four groups (6–8 animals each). The first group served as the control group. The second group was treated with curcumin (200 mg/kg p.o.) [10] suspended in 1% aqueous solution of carboxymethyl cellulose daily for three consecutive days and served as positive control. The third group was injected with methotrexate (7 mg/kg, i.p.) [11] daily for three consecutive days to induce nephrotoxicity. The fourth group was given curcumin (200 mg/kg, p.o.) 1 h before methotrexate (7 mg/kg, i.p.) daily for three consecutive days. All groups received equivalent volumes of the used vehicles. Rats were sacrificed 24 h after the last methotrexate injection, and blood samples were collected and centrifuged at 3000 ×g for 10 min to obtain clear sera. The longitudinal section of the left kidney was excised from each animal for histological and immunohistochemical examination. The renal cortex of the rest of the kidneys were snap frozen in liquid nitrogen, stored at −80°C, and subsequently homogenized in cold potassium phosphate buffer (0.05 M, pH 7.4) for various biochemical analyses.

2.3. Biochemical Analysis

Using commercially available kits, serum levels of creatinine and urea (Diamond Diagnostics, Egypt) as well as renal glutathione peroxidase and superoxide dismutase (Biodiagnostic, Egypt) activities were quantified according to the manufacturers’ guidelines. Renal TNF-α assay was performed with rat TNF-α ELISA kit (RayBiotech, Inc., GA, USA) according to supplier’s instructions. Renal cortex lipid peroxidation was determined as thiobarbituric acid reacting substance and is expressed as equivalents of malondialdehyde, using 1,1,3,3-tetramethoxypropane as standard [12]. Renal cortex nitric oxide level was measured as total nitrite/nitrate, the stable degradation products of nitric oxide, by reduction of nitrate into nitrite using copperized cadmium, followed by color development with Griess reagent in acidic medium [13].

2.4. Histological and Immunohistochemical Examination

Renal tissue samples were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin for histological examination using light microscopy. Three sections from each animal group were subjected to semiquantitative microscopical analysis using light microscopy (Olympus CX41). Renal changes were graded as mild, moderate, or severe. Scores +, ++, and +++ are mild, moderate, and severe levels, revealing less than 25, 50, and 75% histopathological alterations of total fields examined, respectively.

For immunohistochemical detection of COX-2 expression, UltraVision ONE HRP polymer detection system (Thermo Fisher Scientific Inc./Lab Vision, Fremont, CA, USA) was used according to the manufacturer’s protocol. Briefly, kidney sections were deparaffinized and rehydrated. Nonspecific binding of IgG was blocked using Ultra V block for 10 min at room temperature. The sections were then incubated with ready-to-use monoclonal COX-2 antibody for 1 h. After three washes, the sections were incubated for further 30 min with UltraVision One HRP polymer. Color reaction was developed by incubation with diaminobenzidine. The slides were then counterstained, dehydrated, and mounted.

2.5. Statistical Analysis

The data are expressed as means ± SEM. Statistical analysis was performed by one-way ANOVA followed by Tukey-Kramer postanalysis test for multiple comparisons with being considered as statistically significant.

3. Results

3.1. Effects of Curcumin on Renal Functions

Serum creatinine and urea levels were assessed as markers of renal functions. Curcumin treatment in methotrexate-intoxicated rats significantly decreased serum creatinine and urea levels compared to methotrexate alone treated rats. On the other hand, curcumin alone did not alter renal function markers (Figures 1(a) and 1(b)).

3.2. Effects of Curcumin on Renal Histopathological Changes

Histopathological changes were screened to support the results of the classical markers of renal functions. Both control and curcumin-treated groups showed normal histological pattern. Histopathological examination revealed that injection of methotrexate produced degeneration of renal tubules that showed cystic luminal dilatation as compared with control group. Curcumin administration was able to restore methotrexate-induced histopathological damage (Figures 2(a)2(d); Table 1).

GroupsTubular degenerationTubular dilatationGlomerular degeneration

MTX + curcumin++0

Score level 0 was considered normal. Scores +, ++, and +++ are mild, moderate, and severe levels, revealing less than 25, 50 and 75% histopathological alterations of total fields examined, respectively. Score represents values obtained from tissue sections of 3 animals of each group.
3.3. Effects of Curcumin on Renal Malondialdehyde, Nitric Oxide, Glutathione Peroxidase, and Superoxide Dismutase

Oxidative stress was assessed through measuring renal malondialdehyde and nitrite/nitrate levels as well as glutathione peroxidase and superoxide dismutase activities. Renal malondialdehyde was evaluated as an indicator of renal lipid peroxidation and nitrite/nitrate as an indicator of renal nitric oxide level. Curcumin treatment significantly suppressed both lipid peroxidation and the elevation of NO levels in comparison with methotrexate-intoxicated group (Figures 3(a) and 3(b)). Moreover, curcumin treatment significantly increased renal glutathione peroxidase and superoxide dismutase activities compared to methotrexate-treated group (Figures 3(c) and 3(d)).

3.4. Effects of Curcumin on TNF-α Level and COX-2 Expression

The inflammatory mediators TNF-α and COX-2 were assessed. Curcumin treatment significantly decreased the elevation of TNF-α levels in comparison with methotrexate-intoxicated group (Figures 4(a)–4(d)). Immunohistochemical staining of rat kidney showed that COX-2 protein was expressed in renal cortex mainly in the macula densa cells of some distal tubule in the control and curcumin treated groups (Figures 5(a) and 5(b)). Negative expression was noticed in the renal medulla (Figures 6(a) and 6(b)). In methotrexate-treated group, high COX-2 expression was observed in different degenerated cortical tubules (proximal and distal convoluted tubules). Interestingly, in some tubular cells, there was translocation of the expression from the cytoplasm to the nucleus (Figure 5(c)). Most of the medullary tubules exhibited COX-2 staining (Figure 6(c)). COX-2 staining was diminished in the methotrexate and curcumin treated group both in the renal cortex (Figure 5(d)) and renal medulla (Figure 6(d)).

4. Discussion

Curcumin exerts a variety of pleiotropic effects including antioxidant and anti-inflammatory actions, which should facilitate better protection from methotrexate nephrotoxicity. In the present study, curcumin significantly decreased serum creatinine as well as urea levels and attenuated histopathological alterations in methotrexate-intoxicated rats. Consistent with these results, treatment with curcumin significantly decreased creatinine as well as blood urea nitrogen levels and reduced histopathological changes associated with 5/6 nephrectomized rats [14] and cisplatin-induced nephrotoxicity [8].

Since oxidative stress plays an important role in the development of methotrexate nephrotoxicity, several oxidative stress parameters were therefore assessed. In present study, the ability of curcumin to increase renal glutathione peroxidase and superoxide dismutase activities is in line with the finding of Tapia et al. [14] who found that curcumin prevented the decrease in the activity of antioxidant enzymes including glutathione peroxidase and superoxide dismutase in rat remnant kidney. On the other hand, in agreement with the current study, several previous studies [5, 14] denoted similar findings concerning the ability of curcumin to decrease lipid peroxidation in rats subjected to 5/6 nephrectomy. This inhibitory effect of curcumin on lipid peroxidation could be secondary to its antioxidant activity. Alternatively, in harmony with our study, curcumin decreased renal nitric oxide levels in gentamicin- and cholestasis- induced renal injury ([7] and [15], resp.). Christo et al. [16] reported that nitric oxide has a role in the acute renal failure because of the fact that the free radical nature of nitric oxide might contribute to tubular damage. Additionally, nitric oxide increases renal injury through its reaction with superoxide radical and generation of a cytotoxic peroxynitrite [17], which could damage the tubular cells resulting in renal failure. The decrease in nitric oxide level may be due to decrease in inducible nitric oxide synthase level as curcumin is reported to reduce it [7]. Moreover, sustained inducible nitric oxide synthase-mediated nitric oxide generation may mediate lipid peroxidation [18]. In addition, oxidative stress is known to stimulate transcription factors, including nuclear factor-κB (NF-κB) [19]. Meanwhile, NF-κB is known to activate many genes, including iNOS [20].

Inflammatory mediators including TNF-α and COX-2 play important roles in the pathogenesis of methotrexate nephrotoxicity. In accordance with the present study, the reduced renal TNF-α level and COX-2 expression in curcumin-treated methotrexate group is strengthened by several studies in rat kidney [5, 21]. TNF-α stimulates the production of other inflammatory mediators including COX-2 along with inducible nitric oxide synthase and curcumin can reduce the levels of these mediators [6].

5. Conclusions

Curcumin treatment attenuated methotrexate nephrotoxicity in rats partly through its antioxidant and anti-inflammatory properties by preserving glutathione peroxidase and superoxide dismutase activities and inhibiting TNF-α and COX-2 production.

Conflict of Interests

The authors reported no conflict of interests.


  1. B. C. Widemann and P. C. Adamson, “Understanding and managing methotrexate nephrotoxicity,” Oncologist, vol. 11, no. 6, pp. 694–703, 2006. View at: Publisher Site | Google Scholar
  2. I. Asvadi, B. Hajipour, A. Asvadi, N. A. Asl, L. Roshangar, and A. Khodadadi, “Protective effect of pentoxyfilline in renal toxicity after methotrexate administration,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 9, pp. 1003–1009, 2011. View at: Google Scholar
  3. E. Devrim, R. Çetin, B. Kiliçoǧlu, B. Imge Ergüder, A. Avci, and I. Durak, “Methotrexate causes oxidative stress in rat kidney tissues,” Renal Failure, vol. 27, no. 6, pp. 771–773, 2005. View at: Publisher Site | Google Scholar
  4. Y. Cağlar, H. Ozgür, I. Matur et al., “Ultrastructural evaluation of the effect of N-acetylcysteine on methotrexate nephrotoxicity in rats,” Histology and Histopathology, vol. 28, no. 7, pp. 865–874, 2013. View at: Google Scholar
  5. V. Soetikno, F. R. Sari, A. P. Lakshmanan et al., “Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway,” Molecular Nutrition & Food Research, vol. 57, no. 9, pp. 1649–1659, 2013. View at: Publisher Site | Google Scholar
  6. S. Shishodia, “Molecular mechanisms of curcumin action: gene expression,” BioFactors, vol. 39, no. 1, pp. 37–55, 2013. View at: Google Scholar
  7. R. Manikandan, M. Beulaja, R. Thiagarajan, A. Priyadarsini, R. Saravanan, and M. Arumugam, “Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats,” European Journal of Pharmacology, vol. 670, no. 2-3, pp. 578–585, 2011. View at: Publisher Site | Google Scholar
  8. M. Ueki, M. Ueno, J. Morishita, and N. Maekawa, “Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice,” Journal of Bioscience and Bioengineering, vol. 115, no. 5, pp. 547–551, 2013. View at: Publisher Site | Google Scholar
  9. J. Huang, K. Huang, T. Lan et al., “Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway,” Molecular and Cellular Endocrinology, vol. 365, no. 2, pp. 231–240, 2013. View at: Google Scholar
  10. M. Waseem, P. Kaushik, and S. Parvez, “Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced nephrotoxicity,” Cell Biochemistry and Function, 2013. View at: Publisher Site | Google Scholar
  11. P. Abraham, V. K. Kolli, and S. Rabi, “Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats,” Cell Biochemistry and Function, vol. 28, no. 5, pp. 426–433, 2010. View at: Publisher Site | Google Scholar
  12. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology C, vol. 52, pp. 302–310, 1978. View at: Publisher Site | Google Scholar
  13. K. V. Sastry, R. P. Moudgal, J. Mohan, J. S. Tyagi, and G. S. Rao, “Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy,” Analytical Biochemistry, vol. 306, no. 1, pp. 79–82, 2002. View at: Publisher Site | Google Scholar
  14. E. Tapia, V. Soto, K. M. Ortiz-Vega et al., “Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 269039, 14 pages, 2012. View at: Publisher Site | Google Scholar
  15. M. Tokaç, G. Taner, S. Aydın et al., “Protective effects of curcumin against oxidative stress parameters and DNA damage in the livers and kidneys of rats with biliary obstruction,” Food and Chemical Toxicology, 2013. View at: Publisher Site | Google Scholar
  16. J. S. Christo, A. M. Rodrigues, M. G. Mouro et al., “Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats,” Nitric Oxide, vol. 24, no. 2, pp. 77–83, 2011. View at: Publisher Site | Google Scholar
  17. L. M. Walker, P. D. Walker, S. Z. Imam, S. F. Ali, and P. R. Mayeux, “Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N6-(1-iminoethyl)lysine,” Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 1, pp. 417–422, 2000. View at: Google Scholar
  18. M. S. Goligorsky, S. V. Brodsky, and E. Noiri, “Nitric oxide in acute renal failure: NOS versus NOS,” Kidney International, vol. 61, no. 3, pp. 855–861, 2002. View at: Publisher Site | Google Scholar
  19. C. Bubici, S. Papa, K. Dean, and G. Franzoso, “Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance,” Oncogene, vol. 25, no. 51, pp. 6731–6748, 2006. View at: Publisher Site | Google Scholar
  20. H. Kleinert, A. Pautz, K. Linker, and P. M. Schwarz, “Regulation of the expression of inducible nitric oxide synthase,” European Journal of Pharmacology, vol. 500, no. 1–3, pp. 255–266, 2004. View at: Publisher Site | Google Scholar
  21. S. S. Ghosh, R. Krieg, H. D. Massey et al., “Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase,” American Journal of Physiology, vol. 302, no. 4, pp. F439–F454, 2012. View at: Publisher Site | Google Scholar

Copyright © 2013 Mohamed A. Morsy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.